Butyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells

Beneficial Microbes

Volumn 8, Issue 5, 2017, Pages 841-847

  Elce, A ^a,b   Amato, F ^b,c   Zarrilli, F ^b,d   Calignano, A ^c   Troncone, R ^c   Castaldo, G ^b,c   Canani, R B ^c  

^a UNIVERSITÀ TELEMATICA PEGASO   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF MOLISE   (Italy)

Author keywords

Inflammation; Membrane carrier; Short chain fatty acids

Indexed keywords

BUTYRIC ACID; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR; ANTIINFLAMMATORY AGENT; BUTYRIC ACID DERIVATIVE; IMMUNOLOGIC FACTOR;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; LIMIT OF QUANTITATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; CELL CULTURE; COLON; DRUG EFFECT; EPITHELIUM CELL; GENE EXPRESSION PROFILING; IMMUNOLOGY; METABOLISM; SMALL INTESTINE;

ANTI-INFLAMMATORY AGENTS; BUTYRATES; CELLS, CULTURED; COLON; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; IMMUNOLOGIC FACTORS; INTESTINE, SMALL; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 85031417662     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2016.0197     Document Type: Article

References (32)

1. Baronowski, M., 2008. Biological role of liver X receptors. Journal of Physiology and Pharmacology 59: 31-55
2. Biasi, F., Leonarduzzi, G., Oteiza, P.I. and Poli, G., 2013. Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxidants and Redox Signaling 19: 1711-1747
3. Canani, R.B., Di Costanzo, M., Leone, L., Pedata, M., Meli, R. and Calignano, A., 2011. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology 17: 1519-1528
4. Canani, R.B., Terrin, G., Cirillo, P., Castaldo, G., Salvatore, F., Cardillo, G., Cozzuto, A. and Troncone, R., 2004. Butyrate as an effective treatment of congenital chloride diarrea. Gastroenterology 127: 630-634
5. Canani, R.B., Terrin, G., Elce, A., Pezzella, V., Heinz-Herian, P., Pedrolli, A., Centenari, C., Amato, F., Tomaiuolo, R., Calignano, A., Troncone, R. and Castaldo, G., 2013. Genotype-dependency of butyrate efficacy in children with congenital chloride diarrhea. Orphanet Journal of Rare Diseases 8: 194
6. Chen, W.X., Ren, L.H. and Shi, R.H., 2014. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis. World Journal of Gastroenterology 20: 15657-15663
7. Czura, C.J., Wang, H. and Tracey, K.J., 2001. Dual roles for HMGB1: DNA binding and cytokine. Journal of Endotoxin Research 7: 315-321
8. Donohoe, D.R., Collins, L.B., Wali, A., Bigler, A., Sun, W. and Bultman, S.J., 2012. The Warbung effect dictates the mechanism of butyrate mediated histone acetylation and cell proliferation. Molecular Cell 48: 612-626
9. Felice, C., Lewis, A., Armuzzi, A., Lindsay, J.O. and Silver, A., 2015. Selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics 41: 26-38
10. Frank, D.N., St Amand, A.L., Feldman, R.A., Boedeker, E.C., Harpaz, N. and Pace, N.R., 2007. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the USA 104: 13780-13785
11. Fuyitake, Y., Ohtsuka, Y., Ikuse, T., Ohtani, K., Aoyagi, Y., Fujii, T., Kudo, T., Ishii, M. and Shimizu, T., 2013. Analysis of inflammatory signals in Japanese children with Crohn's disease. Pediatrics International 55: 753-756
12. Gao, M., Bu, L., Ma, Y. and Liu, D., 2013. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice. PLoS ONE 8: e65641
13. Goncalves, P., Gregorio, I., Caterino, T.A. and Martel, F., 2013. The effect of oxidative stress upon the intestinal epithelial uptake of butyrate. European Journal of Pharmacology 699: 88-100
14. Gorka, P., Pietrzak, P., Kotunia, A., Zabielski, R. and Kowalski, Z.M., 2014. Effect of method of delivery of sodium butyrate on maturation of the small intestine in newborn calves. Journal of Dairy Science 97: 1026-1035
15. Guilloteau, P., Martin, L., Eeckhaut, V., Ducatelle, R., Zabielski, R. and Van Immerseel, F., 2010. From the gut to peripheral tissues: the multiple effects of butyrate. Nutrition Research Reviews 23: 366-384
16. Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J. and Brummer, R.J., 2008. Review article: the role of butyrate on colonic function. Alimentary Pharmacology and Therapeutics 27: 104-119
17. Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., Nishimoto, N., Yoshizaki, K., Shimoyama, T. and Kishimoto, T., 2004. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 126: 989-996
18. Kimura, R., Takahashi, N., Goto, T., Murota, K. and Kawada, T., 2013. Activation of peroxisome proliferator-activated receptoralpha (PPARalpha) in proximal intestine improves postprandial lipidemia in obese diabetic KK-Ay mice. Obesity Research and Clinical Practice 7: e353-e360
19. Luhrs, H., Gerke, T., Muller, J.G., Melcher, R., Schauber, J., Boxberge, F., Scheppach, W. and Menzel, T., 2002. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scandinavian Journal of Gastroenterology 37: 458-466
20. Mueller, C., 2012. Danger-associated molecular patterns and inflammatory bowel disease: is there a connection? Digestive Diseases 30: 40-46
21. Ock, C.Y., Kim, E.H., Choi, D.J., Lee, H.J., Hahm, K.B. and Chung, M.H., 2012. 8-hydrozydeoxyguanosine: not mere biomarker for oxidative stress, but remedy for oxidative stress-implicated gastrointestinal diseases. World Journal Gastroenterology 18: 302-308
22. Palumbo, R. and Bianchi, M.E., 2004. High mobility group box 1 protein, a cue for stem cell recruitment. Biochemical Pharmacology 68: 1165-1170
23. Pfaffl, M.W., 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29: 2003-2007
24. Schenk, M., Bouchon, A., Seibold, F. and Mueller, C., 2007. TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. Journal of Clinical Investigation 117: 3097-3106
25. Steppe, M., Van Nieuwerburgh, F., Vercauteren, G., Boyen, F., Eeckhaut, V., Deforce, D., Haesebrouck, F., Ducatelle, R. and Van Immerseel, F., 2014. Safety assessment of the butyrate-producing Butyricicoccus pullicaecorum strain 25-3(T), a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing. Food and Chemical Toxicology 72: 129-137
26. Stojcev, Z., Krokowicz, L., Krokowicz, P., Szczepkowski, M., Borycka-Kiciak, K., Kiciak, A. Walkowiak, J., Drews, M. and Banasiewicz, T., 2013. Early treatment and prevention of the radiation proctitis-composite enemas containing sodium butyrate. International Journal of Colorectal Diseases 28: 1731-1732
27. Vitali, R., Stronati, L., Negroni, A., Di Nardo, G., Pierdomenico, M., Del Giudice, E., Rossi, P. and Cucchiara, S., 2011. Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease. American Journal of Gastroenterology 106: 2029-2040
28. Waldner, M.J. and Neurath, M.F., 2014. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development. Seminars in Immunology 26: 75-79
29. Wang, L.S., Kuo, C.T., Huang, Y.W., Stoner, G.D. and Lechner, J.F., 2012. Gene-diet interactions on colorectal cancer risk. Current Nutrition Reports 1: 132-141
30. Yang, F., Wang, L.K., Li, X., Wang, L.W., Han, X.Q. and Gong, Z.J., 2014. Sodium butyrate protects against toxin-induced acute liver failure in rats. Hepatobiliary and Pancreatic Diseases International 13: 309-315
31. Zhang, L.T., Yao, Y.M., Lu, J.Q., Yan, X.J., Yu, Y. and Sheng, Z.Y., 2007. Sodium butyrate prevents lethality of severe sepsis in rats. Shock 27: 672-677
32. Zhou, J., Chai, F., Lu, G., Hang, G., Chen, C., Chen, X. and Shi, J., 2013. TREM-1 inhibition attenuates inflammation and tumor within the colon. International Immunopharmacology 17: 155-161